Taglietti Marco insider trades
Taglietti Marco has filed 7 Form 4s with the SEC that we hold, for Aquestive Therapeutics, Inc. (AQST) (Director) and Scynexis INC (SCYX) (Chief Executive Officer, Director). Across all of them we count 1 purchase worth $225.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 75,000 shares of Scynexis INC worth $225.0K, dated 2022-04-26. The first filing on our record is dated 2022-02-08 and the latest 2026-06-12.
Aquestive Therapeutics, Inc. (AQST)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Scynexis INC (SCYX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-04-26 | P, purchase reported on Form 4 | 75,000 | $225.0K | 2022-04-28 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1408870) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
